AI Safety
What AI providers state their models reached in safety testing, in their own words, and what outside testers found.
Also: compare models side by side · statements that a capability level was crossed · providers · practices providers document · safety news.
What providers state
Each row is one statement in a provider's own safety document about a capability level of one of its models: the level as the provider names it, whether the provider says the model reached it, and the sentence that says so.
138 of 138
| Model | Level, as the provider names it | The provider states | The provider's sentence |
|---|---|---|---|
| Claude Sonnet 4.5 Anthropic |
ASL-3 Cyber |
Not determined | “Showed meaningful improvements in cyber capabilities, particularly in vulnerability discovery and code analysis;” source |
| Claude Sonnet 4 Anthropic |
ASL-3 Chemical, biological, radiological, nuclear |
Not determined | “specifically, we focused on ruling out asl-4 for both models, as well as ruling out asl-3 for claude sonnet 4.” source |
| Claude Sonnet 4 Anthropic |
ASL-4 Chemical, biological, radiological, nuclear |
Not determined | “specifically, we focused on ruling out asl-4 for both models, as well as ruling out asl-3 for claude sonnet 4.” source |
| Claude Sonnet 3.7 Anthropic |
ASL-4 Autonomy and AI research |
Not determined | “These problems are harder to solve than the previous problems and we consider them as part of our ASL-4 evaluations.” source |
| Claude Opus 4.6 Anthropic |
AI R&D-4 Autonomy and AI research |
Not reached | “Our determination is that Claude Opus 4.6 does not cross either the AI R&D-4 or the CBRN-4 capability threshold.” source |
| Claude Opus 4.6 Anthropic |
ASL-4 Autonomy and AI research |
Not determined | “For AI R&D capabilities, we found that Claude Opus 4.6 has saturated most of our automated evaluations, meaning they no longer provide useful evidence for ruling out ASL-4 level autonomy.” source |
| Claude Opus 4.6 Anthropic |
ASL-3 Chemical, biological, radiological, nuclear |
Reached | “The model crossed or met thresholds on all ASL-3 evaluations except our synthesis screening evasion, consistent with incremental capability improvements driven primarily by better agentic workflows.” source |
| Claude Opus 4.6 Anthropic |
ASL-4 Chemical, biological, radiological, nuclear |
Not reached | “Claude Opus 4.6 is our strongest biology model to date and demonstrates meaningful capability improvements, but we do not believe it merits ASL-4 safeguards.” source |
| Claude Opus 4.6 Anthropic |
CBRN-4 Chemical, biological, radiological, nuclear |
Not reached | “Our determination is that Claude Opus 4.6 does not cross either the AI R&D-4 or the CBRN-4 capability threshold.” source |
| Claude Opus 4.5 Anthropic |
AI R&D-4 Autonomy and AI research |
Not reached | “Our determination is that Claude Opus 4.5 does not cross either the AI R&D-4 or CBRN-4 capability threshold.” source |
| Claude Opus 4.5 Anthropic |
CBRN-4 Chemical, biological, radiological, nuclear |
Not reached | “We determine that Claude Opus 4.5 does not cross the CBRN-4 threshold.” source |
| Claude Opus 4.1 Anthropic |
ASL-4 Autonomy and AI research |
Not reached | “Since Claude Opus 4.1 is deployed with ASL-3 protections, we focused on confirming it remains well below ASL-4 thresholds across CBRN (Chemical, Biological, Radiological, and Nuclear), cyber, and autonomy domains.” source |
| Claude Opus 4.1 Anthropic |
ASL-4 Chemical, biological, radiological, nuclear |
Not reached | “Since Claude Opus 4.1 is deployed with ASL-3 protections, we focused on confirming it remains well below ASL-4 thresholds across CBRN (Chemical, Biological, Radiological, and Nuclear), cyber, and autonomy domains.” source |
| Claude Opus 4.1 Anthropic |
ASL-4 Cyber |
Not reached | “Since Claude Opus 4.1 is deployed with ASL-3 protections, we focused on confirming it remains well below ASL-4 thresholds across CBRN (Chemical, Biological, Radiological, and Nuclear), cyber, and autonomy domains.” source |
| Claude Opus 4 Anthropic |
ASL-3 Chemical, biological, radiological, nuclear |
Not determined | “for claude opus 4, our evaluations showed that, whereas we could confidently rule out asl-4 capabilities, we could not conclusively rule out asl-3 capabilities—which led to our precautionary decision to deploy it with asl-3 protections .” source |
| Claude Opus 4 Anthropic |
ASL-4 Chemical, biological, radiological, nuclear |
Not reached | “for claude opus 4, our evaluations showed that, whereas we could confidently rule out asl-4 capabilities, we could not conclusively rule out asl-3 capabilities—which led to our precautionary decision to deploy it with asl-3 protections .” source |
| Claude Haiku 4.5 Anthropic |
ASL-3 Autonomy and AI research |
Not reached | “Our evaluation results showed that Claude Haiku 4.5 remained well below ASL-3 thresholds across all domains of concern.” source |
| Claude Haiku 4.5 Anthropic |
ASL-3 Chemical, biological, radiological, nuclear |
Not reached | “Our evaluation results showed that Claude Haiku 4.5 remained well below ASL-3 thresholds across all domains of concern.” source |
Previous · Page 4 of 4
What outside testers report
Each row is one result from a government evaluator, independent lab, academic or security firm that tested a model, quoted from where it is reported.
1911 of 1911
| Model | Tester | Test | What was found |
|---|---|---|---|
| Grok 4.6 Cursor |
Independent lab Independent lab · 2026-08-12 |
vals index Other |
“Vals Index (Vals AI) is an independent composite of real-world industry and agentic evaluations spanning finance, legal, healthcare, and coding-adjacent professional work.” source |
| Grok 4.6 Cursor |
Independent lab Independent lab · 2026-08-12 |
harvey legal agent benchmark Other |
“Harvey Legal Agent Benchmark (LAB) is a long-horizon legal-agent evaluation: agents complete realistic, multi-step legal work over client-matter files and produce reviewable work product graded with expert all-pass rubrics.” source |
| Grok 4.6 Cursor |
Independent lab Independent lab · 2026-08-12 |
third-party evaluator testing of cyber capabilities Cyber |
“We additionally supplied the model without restrictions to third-party evaluators to validate the above results.” source |
| Solar Pro 4 Upstage |
Independent lab Independent lab · 2026-08-11 |
τ³-banking Prompt injection and agents |
“Multi-turn tool use (τ³-Banking): 23” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
LLM agent-BT evaluation Chemical, biological, radiological, nuclear |
“In this report, we evaluated LLM Agents on their use of BTs to redesign biomolecules to evade nucleic acid synthesis screening measures.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
nucleic acid synthesis screening evasion testing of agent-designed DNA sequences Chemical, biological, radiological, nuclear |
“The DNA sequences designed by our Agents were then tested to gauge whether they would be able to evade nucleic acid synthesis screening measures.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
biomolecule redesign task Chemical, biological, radiological, nuclear |
“In three out of 30 instances, all of which were CYOA runs, Gemini’s redesigned Protein-2 was able to pass the entirety of our scoring pipeline, including evasion of a commercial sequence screening process (Figure 2.2).” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
simulated screening mockup Chemical, biological, radiological, nuclear |
“Interestingly, although Gemini’s redesigned OmpA proteins passed validation and structural scoring gates more frequently than any other biomolecule (20/30 attempts), they met with a nearly 100% failure rate at the screening gate, with only one OmpA redesign passing our simulated screening check.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
biomolecule redesign evaluation Chemical, biological, radiological, nuclear |
“Similar to Gemini’s results, we found that three of 30 redesign attempts resulted in Protein-2 redesigns that passed all grading checkpoints and were able to bypass commercial nucleic acid synthesis screening (Figure 2.4).” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
peptide-2 redesign Chemical, biological, radiological, nuclear |
“For both peptides, DeepSeek’s performance characteristics were similar to those of Gemini: it performed relatively well on glucagon redesign (14/30 total attempts were successful) and succeeded in a handful of attempts with Peptide-2 in the ProteinMPNN environment (Figures 2.3 and 2.4).” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
ompA protein redesign Chemical, biological, radiological, nuclear |
“Though both models had similarly high overall rates of OmpA redesign success on checks for validation and for structure and function, DeepSeek’s OmpA protein redesign was significantly more successful at evading our simulated screening pipeline (Figure 2.4).” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
viral genome redesign Chemical, biological, radiological, nuclear |
“We tested DeepSeek V4 Pro on this task in the CYOA BT configuration.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
protein-2 redesign for screening evasion Chemical, biological, radiological, nuclear |
“Gemini 3.1 Pro was able to successfully redesign Protein-2 for screening evasion in three of 30 attempts.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
simulated screening process Chemical, biological, radiological, nuclear |
“For all but one of our test biomolecules, we implemented a simulated screening process that utilized the NCBI BLAST tool.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
Parvovirus B19 redesign evaluation Chemical, biological, radiological, nuclear |
“We did not implement the function check component of our full viral genome here, as all Agent submissions failed the preceding validity or structure checks.” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
viral genome redesign and screening evasion case study Chemical, biological, radiological, nuclear |
“Appendix E: Viral genome redesign and screening evasion case study” source |
| Gemini 3.1 Pro Google DeepMind |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
per-criterion scoring results Chemical, biological, radiological, nuclear |
“The heatmaps of Figures D.1 and D.2 show the number of attempts, out of 10, in which Gemini 3.1 Pro and DeepSeek V4 Pro achieved each of our validity, structure, and function- related scoring criteria.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
peptide and protein redesign task Chemical, biological, radiological, nuclear |
“We tested autonomous Agents, driven by frontier LLMs, on their ability to use BTs for peptide and protein redesign tasks that could potentially enable evasion of nucleic acid screening measures.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
nucleic acid screening pipelines Chemical, biological, radiological, nuclear |
“Sequences that scored highly on those metrics were evaluated by nucleic acid screening pipelines to determine whether the Agent had sufficiently obfuscated the sequence that encoded the desired biomolecule so that it could evade the screening measures in place at some major commercial nucleic acid synthesis providers.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
LLM agent-BT evaluation (DNA sequence redesign task to evade nucleic acid synthesis screening) Chemical, biological, radiological, nuclear |
“In this report, we evaluated LLM Agents on their use of BTs to redesign biomolecules to evade nucleic acid synthesis screening measures.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
biomolecule redesign task (peptide and protein redesign to evade sequence screening) Chemical, biological, radiological, nuclear |
“We found that both Gemini 3.1. Pro and DeepSeek V4 Pro were able to redesign peptides or proteins to evade sequence screening in several attempts.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
nucleic acid synthesis screening (simulated screening mockup and commercial screening algorithm) Chemical, biological, radiological, nuclear |
“The peptide and protein redesigns generated by our Agents were screened using one of two pipelines: three sets of Agent designs were passed through a simulated screening mockup, while Protein-2 designs were instead tested with a commercial screening algorithm.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
biomolecule redesign evaluation (protein-2, peptide-2, glucagon, OmpA redesign across CYOA, ProteinMPNN, Evo 2, and RFdiffusion + ProteinMPNN configurations) Chemical, biological, radiological, nuclear |
“Similar to Gemini’s results, we found that three of 30 redesign attempts resulted in Protein-2 redesigns that passed all grading checkpoints and were able to bypass commercial nucleic acid synthesis screening (Figure 2.4).” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
glucagon redesign Chemical, biological, radiological, nuclear |
“For both peptides, DeepSeek’s performance characteristics were similar to those of Gemini: it performed relatively well on glucagon redesign (14/30 total attempts were successful) and succeeded in a handful of attempts with Peptide-2 in the ProteinMPNN environment (Figures 2.3 and 2.4).” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
viral genome redesign (parvovirus B19 proteins) Chemical, biological, radiological, nuclear |
“We tested DeepSeek V4 Pro on this task in the CYOA BT configuration.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
parvovirus B19 full viral genome redesign task Chemical, biological, radiological, nuclear |
“We found that the DeepSeek V4 Pro Agent could not successfully redesign all parvovirus B19 proteins.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
simulated screening process for redesigned viral proteins Chemical, biological, radiological, nuclear |
“Four out of ten redesigns were able to evade screening across all proteins (Figure E.2).” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
protein-2 redesign task Chemical, biological, radiological, nuclear |
“DeepSeek V4 Pro also succeeded at the Protein-2 redesign task in three of 30 attempts.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
nucleic acid synthesis screening test Chemical, biological, radiological, nuclear |
“In this report, we made use of a commercial nucleic acid synthesis vendor’s screening system and our own simulated screening pipeline, but a number of other screening approaches exist.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
synthesis screening evasion tests Chemical, biological, radiological, nuclear |
“In our synthesis screening evasion tests, we notified our research partner of our intention and research objectives, then worked with them to confirm sequence submission details.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
biomolecule redesign tasks Chemical, biological, radiological, nuclear |
“We paired each of our biomolecule redesign tasks with BT environments as described in Table A.1.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
sequence screening checkpoint Chemical, biological, radiological, nuclear |
“The DNA sequences designed by the Agents were subject to the sequence screening checkpoint described in Appendix C.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
validity checks Chemical, biological, radiological, nuclear |
“Validity checks were used to determine whether the generated DNA sequences were biologically coherent and useful for the task.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
structure and function metric thresholds Chemical, biological, radiological, nuclear |
“Structure and function metric thresholds were set to determine whether the biomolecules encoded by the generated DNA sequences retained general folding structures similar to those of their wildtype templates.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
simulated screening process that utilized the ncbi blast tool Chemical, biological, radiological, nuclear |
“For all but one of our test biomolecules, we implemented a simulated screening process that utilized the NCBI BLAST tool.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
commercial screening pipeline Chemical, biological, radiological, nuclear |
“For Protein-2, which would be expected to be identified by commercial screening processes, we worked with a nucleic acid synthesis provider to utilize their screening pipeline for testing redesigns.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
viral genome redesign and screening evasion case study Chemical, biological, radiological, nuclear |
“We did not implement the function check component of our full viral genome here, as all Agent submissions failed the preceding validity or structure checks.” source |
| DeepSeek-V4-Pro DeepSeek |
RAND (CAST / Project Canary) Independent lab · 2026-08-11 |
validity, structure, and function-related scoring criteria Chemical, biological, radiological, nuclear |
“The heatmaps of Figures D.1 and D.2 show the number of attempts, out of 10, in which Gemini 3.1 Pro and DeepSeek V4 Pro achieved each of our validity, structure, and function- related scoring criteria.” source |
| Ling-3.0-tiny InclusionAI (Ant Group) |
Independent lab Independent lab · 2026-08-10 |
Artificial Analysis Intelligence Index v4.1.1 Other |
“Ling-3.0-tiny achieves a score of 25 on the Artificial Analysis Intelligence Index v4.1.1 and 16 on the Artificial Analysis Agentic Index.” source |
| Ling-3.0-tiny InclusionAI (Ant Group) |
Independent lab Independent lab · 2026-08-10 |
Terminal-Bench 2.1 Other |
“Terminal-Bench 2.1: Evaluated under the Artificial Analysis (AA) protocol using the default Terminus 2 harness, a unified 2-hour timeout, the provided JSON parser in preserve-thinking mode, and 3 runs per task (mean).” source |